Valiant Organics Limited (VALIANTORG.NS)
- Previous Close
374.70 - Open
390.00 - Bid 393.40 x --
- Ask --
- Day's Range
382.15 - 393.40 - 52 Week Range
227.05 - 456.20 - Volume
111,531 - Avg. Volume
115,570 - Market Cap (intraday)
11.017B - Beta (5Y Monthly) 0.32
- PE Ratio (TTM)
-- - EPS (TTM)
-9.97 - Earnings Date May 22, 2025 - May 26, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Feb 10, 2023
- 1y Target Est
--
Valiant Organics Limited, a chemical manufacturing company, manufactures and markets specialty chemicals in India. Its products include para chloro phenol, ortho chloro phenol, para flouro aniline, 4-flouro-N-isopropylaniline, 2,4-dichlorophenoxyacetic acid, 2,4 di chloro phenol, 2,6 di chloro phenol, n-isopropyl para chloro aniline, and 2,4,6 tri chloro phenol; ortho anisidine, para anisidine, ortho toluidine 5 sulfonic acid, ortho nitro aniline para sulphonic acid, ortho amino phenol, para nitro aniline, ortho chloro para nitro aniline, IPPCA, meta chloro aniline, and paraamino phenol; and 6 acetyl oapsa, OA acetanilide, and PA acetanilide. The company also provides ortho chloro para nitro aniline, OT5SA, 4b and 2b acid, ortho nitro anisole, and para nitro anisole. Its products are primarily used as intermediates in agro chemicals, dyes, pigments, pharmaceuticals, cosmetics, specialty chemicals, polymers, and veterinary drugs. The company also exports its products to Europe, Asia, and the United States. Valiant Organics Limited was founded in 1984 and is based in Mumbai, India.
www.valiantorganics.comRecent News: VALIANTORG.NS
View MorePerformance Overview: VALIANTORG.NS
Trailing total returns as of 5/19/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: VALIANTORG.NS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: VALIANTORG.NS
View MoreValuation Measures
Market Cap
10.47B
Enterprise Value
12.37B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.27
Price/Book (mrq)
1.46
Enterprise Value/Revenue
1.79
Enterprise Value/EBITDA
44.14
Financial Highlights
Profitability and Income Statement
Profit Margin
-3.64%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
6.92B
Net Income Avi to Common (ttm)
-251.54M
Diluted EPS (ttm)
-9.97
Balance Sheet and Cash Flow
Total Cash (mrq)
91.67M
Total Debt/Equity (mrq)
28.26%
Levered Free Cash Flow (ttm)
--